A carregar...

microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models

Glioblastoma (GBM) is the most frequently diagnosed malignant human glioma, and current median patient survival is less than two years despite maximal surgery followed by temozolomide chemoradiation therapies. Novel microRNA-related therapies are now being developed for cancers such as GBM. Differen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Alrfaei, Bahauddeen M., Vemuganti, Raghu, Kuo, John S.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828259/
https://ncbi.nlm.nih.gov/pubmed/24244722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0080865
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!